{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:10Z","timestamp":1783498450126,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Association for frontotemporal Dementias Research","award":["Grant 2009"],"award-info":[{"award-number":["Grant 2009"]}]},{"name":"The Netherlands organization for Scientific Research","award":["HCMI 056\u201013\u2010018"],"award-info":[{"award-number":["HCMI 056\u201013\u2010018"]}]},{"name":"ZonMw Memorabel","award":["733050103"],"award-info":[{"award-number":["733050103"]}]},{"name":"ZonMw Memorabel","award":["733050813"],"award-info":[{"award-number":["733050813"]}]},{"name":"Bluefield to cure FTD project"},{"name":"ZonMw Onderzoeksprogramma Dementie","award":["10510032120002"],"award-info":[{"award-number":["10510032120002"]}]},{"name":"European Reference Network on Rare Neurological Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prior research on genetic frontotemporal dementia (FTD) has examined the psychological impact of predictive testing, leaving other effects of genetic awareness largely unexplored. This study examined whether genetic awareness is associated with cognitive, behavioral, and neuropsychiatric outcomes in individuals from genetic FTD families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From a longitudinal genetic cohort study, we included 228 individuals (age 18\u201370\u00a0years) from families with different underlying pathogenic variants. 99 individuals were aware of their genetic status, of which 75 pathogenic variant carriers and 24 non-carriers. 129 individuals were unaware of their genetic status, of which 56 carriers and 73 non-carriers. 26 individuals became aware of their genetic status mid-study. We compared baseline and longitudinal cognitive, behavioral, and neuropsychiatric outcomes between the aware and unaware groups, and explored differences in longitudinal slopes before and after becoming aware of the genetic status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cross-sectionally, genetic awareness is associated with the anxiety subdomain of the NPI-Q, but not after FDR correction. Longitudinally, awareness of genetic status was associated with decline in verbal learning, recall, and semantic fluency in carriers. Non-carriers who learned their status mid-study reported fewer depressive symptoms post-disclosure, but depressive symptoms increased over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Awareness of genetic status is associated with faster cognitive decline and greater behavioral and neuropsychiatric symptoms in aware carriers of FTD variants. These findings suggest that genetic awareness is an important factor to consider during personalized guidance and monitoring in clinical trials. Future studies should aim for larger sample sizes to further explore potential effects in genetic subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13892-0","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:06:05Z","timestamp":1781273165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of awareness of genetic status on cognitive, behavioral, and neuropsychiatric outcomes in genetic frontotemporal dementia"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7161-3559","authenticated-orcid":false,"given":"Liset","family":"de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8843-7247","authenticated-orcid":false,"given":"Jackie M.","family":"Poos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8180-0158","authenticated-orcid":false,"given":"Julie F. H.","family":"De Houwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8924-2061","authenticated-orcid":false,"given":"Tine","family":"Swartenbroekx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3406-5842","authenticated-orcid":false,"given":"Olaiya A.","family":"Aro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6399-8170","authenticated-orcid":false,"given":"Ana","family":"Rajicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-6289","authenticated-orcid":false,"given":"Elise G. P.","family":"Dopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2436-0931","authenticated-orcid":false,"given":"Laura","family":"Donker Kaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-7527","authenticated-orcid":false,"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-1858","authenticated-orcid":false,"given":"Lize C.","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"13892_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/JNNP.2010.212225","volume":"82","author":"H Seelaar","year":"2011","unstructured":"Seelaar H, Rohrer JD, Pijnenburg YAL et al (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82:476\u2013486. https:\/\/doi.org\/10.1136\/JNNP.2010.212225","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13892_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neurol.2013.07.010","volume":"169","author":"JD Rohrer","year":"2013","unstructured":"Rohrer JD, Warren JD, Fox NC, Rossor MN (2013) Presymptomatic studies in genetic frontotemporal dementia. Rev Neurol (Paris) 169:820\u2013824. https:\/\/doi.org\/10.1016\/j.neurol.2013.07.010","journal-title":"Rev Neurol (Paris)"},{"key":"13892_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","volume":"19","author":"KM Moore","year":"2020","unstructured":"Moore KM, Nicholas J, Grossman M et al (2020) Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol 19:145\u2013156. https:\/\/doi.org\/10.1016\/S1474-4422(19)30394-1","journal-title":"Lancet Neurol"},{"key":"13892_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/WAD.0000000000000458","volume":"35","author":"A Crook","year":"2021","unstructured":"Crook A, Jacobs C, Newton-John T et al (2021) Patient and relative experiences and decision-making about genetic testing and counseling for familial ALS and FTD: a systematic scoping review. Alzheimer Dis Assoc Disord 35:374\u2013385. https:\/\/doi.org\/10.1097\/WAD.0000000000000458","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"13892_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01749-z","author":"CH Graafland","year":"2025","unstructured":"Graafland CH, Seelaar H, Panman JL et al (2025) \u201cIt seems enormously valuable to me.\u201d perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-025-01749-z","journal-title":"Alzheimers Res Ther"},{"key":"13892_CR6","doi-asserted-by":"publisher","unstructured":"Graafland CH, Donker Kaat L, Richard E et al (2025) Ethics of disclosure of onset-predictive biomarker test results for genetic frontotemporal dementia in the research context. Alzheimers Dement: Diagn Assess Dis Monit 17:e70133. https:\/\/doi.org\/10.1002\/dad2.70133","DOI":"10.1002\/dad2.70133"},{"key":"13892_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/153331750502000408","volume":"20","author":"JL Molinuevo","year":"2005","unstructured":"Molinuevo JL, Pintor L, Peri JM et al (2005) Emotional reactions to predictive testing in Alzheimer\u2019s disease and other inherited dementias. Am J Alzheimers Dis Other Demen 20:233\u2013238. https:\/\/doi.org\/10.1177\/153331750502000408","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"13892_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/WAD.0000000000000494","volume":"36","author":"S Galluzzi","year":"2022","unstructured":"Galluzzi S, Mega A, Di Fede G et al (2022) Psychological impact of predictive genetic testing for inherited Alzheimer Disease and Frontotemporal Dementia: the IT-DIAfN protocol. Alzheimer Dis Assoc Disord 36:118\u2013124. https:\/\/doi.org\/10.1097\/WAD.0000000000000494","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"13892_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10897-017-0195-3","volume":"27","author":"PE Cohn-Hokke","year":"2018","unstructured":"Cohn-Hokke PE, van Swieten JC, Pijnenburg YAL et al (2018) The effect of predictive testing in adult-onset neurodegenerative diseases on social and personal life. J Genet Couns 27:947\u2013954. https:\/\/doi.org\/10.1007\/s10897-017-0195-3","journal-title":"J Genet Couns"},{"key":"13892_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13195-016-0212-Z","volume":"8","author":"SASA Bemelmans","year":"2016","unstructured":"Bemelmans SASA, Tromp K, Bunnik EM et al (2016) Psychological, behavioral and social effects of disclosing Alzheimer\u2019s disease biomarkers to research participants: a systematic review. Alzheimers Res Ther 8:1\u201317. https:\/\/doi.org\/10.1186\/S13195-016-0212-Z","journal-title":"Alzheimers Res Ther"},{"key":"13892_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMOA0809578","volume":"361","author":"RC Green","year":"2009","unstructured":"Green RC, Roberts JS, Cupples LA et al (2009) Disclosure of APOE genotype for risk of Alzheimer\u2019s disease. N Engl J Med 361:245\u2013254. https:\/\/doi.org\/10.1056\/NEJMOA0809578","journal-title":"N Engl J Med"},{"key":"13892_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ALZ.12010","volume":"16","author":"AJ Aschenbrenner","year":"2020","unstructured":"Aschenbrenner AJ, James BD, McDade E et al (2020) Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimers Dement 16:219\u2013228. https:\/\/doi.org\/10.1002\/ALZ.12010","journal-title":"Alzheimers Dement"},{"key":"13892_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/JNNP.69.5.574","volume":"69","author":"B Meiser","year":"2000","unstructured":"Meiser B, Dunn S (2000) Psychological impact of genetic testing for Huntington\u2019s disease: an update of the literature. J Neurol Neurosurg Psychiatry 69:574\u2013578. https:\/\/doi.org\/10.1136\/JNNP.69.5.574","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13892_CR14","doi-asserted-by":"publisher","unstructured":"Lineweaver TT, Bondi MW, Galasko D, Salmon DP (2014) Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry 171(2):201\u20138. https:\/\/doi.org\/10.1176\/appi.ajp.2013.12121590","DOI":"10.1176\/appi.ajp.2013.12121590"},{"key":"13892_CR15","doi-asserted-by":"publisher","unstructured":"Dopper EGP, Rombouts SARB, Jiskoot LC et al (2014) Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology 83:e19\u201326. https:\/\/doi.org\/10.1212\/WNL.0000000000000583","DOI":"10.1212\/WNL.0000000000000583"},{"key":"13892_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.JALZ.2019.05.013","volume":"16","author":"T Miyagawa","year":"2020","unstructured":"Miyagawa T, Brushaber D, Syrjanen J et al (2020) Use of the CDR\u00ae plus NACC FTLD in mild FTLD: data from the ARTFL\/LEFFTDS consortium. Alzheimers Dement 16:79\u201390. https:\/\/doi.org\/10.1016\/J.JALZ.2019.05.013","journal-title":"Alzheimers Dement"},{"key":"13892_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"13892_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1017\/S135561771200077X","volume":"18","author":"S Freitas","year":"2012","unstructured":"Freitas S, Sim\u00f5es MR, Alves L et al (2012) Montreal Cognitive Assessment (MoCA): validation study for vascular dementia. J Int Neuropsychol Soc 18:1031\u20131040. https:\/\/doi.org\/10.1017\/S135561771200077X","journal-title":"J Int Neuropsychol Soc"},{"key":"13892_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/JGS.18124","volume":"71","author":"JS Fasnacht","year":"2023","unstructured":"Fasnacht JS, Wueest AS, Berres M et al (2023) Conversion between the Montreal Cognitive Assessment and the mini-mental status examination. J Am Geriatr Soc 71:869\u2013879. https:\/\/doi.org\/10.1111\/JGS.18124","journal-title":"J Am Geriatr Soc"},{"key":"13892_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/S1355617705050344","volume":"11","author":"W van der Elst","year":"2005","unstructured":"van der Elst W, van Boxtel MPJ, van Breukelen GJP, Jolles J (2005) Rey\u2019s verbal learning test: normative data for 1855 healthy participants aged 24\u201381\u00a0years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 11:290\u2013302. https:\/\/doi.org\/10.1017\/S1355617705050344","journal-title":"J Int Neuropsychol Soc"},{"key":"13892_CR21","unstructured":"Kaplan E, Goodglass H, Weintraub S (2001) Boston Naming Test. Philadelphia, PA: Lea and Febiger"},{"key":"13892_CR22","unstructured":"Corrigan JD, Hinkeldey NS (1987) Relationships between parts A and B of the trail making test. J Clin Psychol. https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/1097-4679%28198707%2943%3A4%3C402%3A%3AAID-JCLP2270430411%3E3.0.CO%3B2-E. Accessed 19 Dec 2025"},{"key":"13892_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1037\/H0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643\u2013662. https:\/\/doi.org\/10.1037\/H0054651","journal-title":"J Exp Psychol"},{"key":"13892_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1155\/2007\/868431","volume":"18","author":"RPC Kessels","year":"2007","unstructured":"Kessels RPC, Gerritsen L, Montagne B et al (2007) Recognition of facial expressions of different emotional intensities in patients with frontotemporal lobar degeneration. Behav Neurol 18:31\u201336. https:\/\/doi.org\/10.1155\/2007\/868431","journal-title":"Behav Neurol"},{"key":"13892_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/JNNP-2011-301849","volume":"83","author":"M Bertoux","year":"2012","unstructured":"Bertoux M, Delavest M, De Souza LC et al (2012) Social cognition and emotional assessment differentiates frontotemporal dementia from depression. J Neurol Neurosurg Psychiatry 83:411\u2013416. https:\/\/doi.org\/10.1136\/JNNP-2011-301849","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13892_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/JNNP.64.5.588","volume":"64","author":"DR Royall","year":"1998","unstructured":"Royall DR, Cordes JA, Polk M (1998) CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry 64:588\u2013594. https:\/\/doi.org\/10.1136\/JNNP.64.5.588","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13892_CR27","doi-asserted-by":"publisher","DOI":"10.1037\/T00742-000","author":"AT Beck","year":"2011","unstructured":"Beck AT, Steer RA, Brown G (2011) Beck depression inventory\u2013II. PsycTESTS Dataset. https:\/\/doi.org\/10.1037\/T00742-000","journal-title":"PsycTESTS Dataset"},{"key":"13892_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/WNL.0B013E3181E04070","volume":"74","author":"E Mioshi","year":"2010","unstructured":"Mioshi E, Hsieh S, Savage S et al (2010) Clinical staging and disease progression in frontotemporal dementia. Neurology 74:1591\u20131597. https:\/\/doi.org\/10.1212\/WNL.0B013E3181E04070","journal-title":"Neurology"},{"key":"13892_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/JNP.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P et al (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12:233\u2013239. https:\/\/doi.org\/10.1176\/JNP.12.2.233","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"13892_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1590\/S1980-57642009DN20200005","volume":"2","author":"HJ Wear","year":"2008","unstructured":"Wear HJ, Wedderburn CJ, Mioshi E et al (2008) The Cambridge Behavioural Inventory revised. Dement Neuropsychol 2:102\u2013107. https:\/\/doi.org\/10.1590\/S1980-57642009DN20200005","journal-title":"Dement Neuropsychol"},{"key":"13892_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1037\/A0038586","volume":"30","author":"RA Lamont","year":"2015","unstructured":"Lamont RA, Swift HJ, Abrams D (2015) A review and meta-analysis of age-based stereotype threat: negative stereotypes, not facts, do the damage. Psychol Aging 30:180\u2013193. https:\/\/doi.org\/10.1037\/A0038586","journal-title":"Psychol Aging"},{"key":"13892_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0146487","volume":"11","author":"CR Pennington","year":"2016","unstructured":"Pennington CR, Heim D, Levy AR, Larkin DT (2016) Twenty years of stereotype threat research: a review of psychological mediators. PLoS ONE 11:e0146487. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0146487","journal-title":"PLoS ONE"},{"key":"13892_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0285220","volume":"18","author":"MP Farina","year":"2023","unstructured":"Farina MP, Saenz J, Crimmins EM (2023) Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires? PLoS ONE 18:e0285220. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0285220","journal-title":"PLoS ONE"},{"key":"13892_CR34","doi-asserted-by":"publisher","first-page":"E201","DOI":"10.1503\/CMAJ.120744\/-\/DC1","volume":"185","author":"A Hr\u00f3bjartsson","year":"2013","unstructured":"Hr\u00f3bjartsson A, Thomsen ASS, Emanuelsson F et al (2013) Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ Can Med Assoc J 185:E201. https:\/\/doi.org\/10.1503\/CMAJ.120744\/-\/DC1","journal-title":"CMAJ Can Med Assoc J"},{"key":"13892_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/JAMANEUROL.2017.4266","volume":"75","author":"A Bertrand","year":"2017","unstructured":"Bertrand A, Wen J, Rinaldi D et al (2017) Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40\u00a0years. JAMA Neurol 75:236. https:\/\/doi.org\/10.1001\/JAMANEUROL.2017.4266","journal-title":"JAMA Neurol"},{"key":"13892_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/WNL.0000000000002895","volume":"87","author":"LC Jiskoot","year":"2016","unstructured":"Jiskoot LC, Dopper EGP, Den Heijer T et al (2016) Presymptomatic cognitive decline in familial frontotemporal dementia. Neurology 87:384\u2013391. https:\/\/doi.org\/10.1212\/WNL.0000000000002895","journal-title":"Neurology"},{"key":"13892_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/JGC4.1981","author":"H Osawa","year":"2025","unstructured":"Osawa H, Matsukawa M, Yoshida A et al (2025) Psychosocial impact on individuals who received negative test results from predictive testing for Huntington\u2019s disease: an exploratory qualitative study. J Genet Couns. https:\/\/doi.org\/10.1002\/JGC4.1981","journal-title":"J Genet Couns"},{"key":"13892_CR38","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/S10897-018-0257-1","volume":"27","author":"E Winnberg","year":"2018","unstructured":"Winnberg E, Winnberg U, Pohlkamp L, Hagberg A (2018) What to do with a second chance in life? Long-term experiences of non-carriers of Huntington\u2019s disease. J Genet Couns 27:1438\u20131446. https:\/\/doi.org\/10.1007\/S10897-018-0257-1","journal-title":"J Genet Couns"},{"key":"13892_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH20031684","author":"A Isselhard","year":"2023","unstructured":"Isselhard A, Lautz Z, T\u00f6pper M et al (2023) Coping self-efficacy and its relationship with psychological morbidity after genetic test result disclosure: results from cancer-unaffected BRCA1\/2 mutation carriers. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/IJERPH20031684","journal-title":"Int J Environ Res Public Health"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13892-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13892-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:21:12Z","timestamp":1783495272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13892-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13892"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13892-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the STROBE reporting guidelines. The investigators were blinded to the genetic status of unaware participants. All participants provided written informed consent. The study has been approved by the Erasmus MC Medical Ethics Committee (MEC-2009-409).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval, registrations, and patient consents"}}],"article-number":"393"}}